XML 32 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
item
Mar. 31, 2012
Dec. 31, 2012
SEGMENT INFORMATION      
Number of reportable segments 2    
Segment reporting information      
Revenues $ 1,068,355 $ 856,103  
Segment profit (loss) 213,810 178,690  
Restructuring, integration and other costs (48,985) (62,337)  
Acquisition-related costs (7,899) (7,505)  
Legal settlements and related fees (4,448) (3,155)  
Acquisition-related contingent consideration 2,185 (9,839)  
Operating income 117,006 61,496  
Interest income 1,596 1,123  
Interest expense (155,315) (102,025)  
Loss on extinguishment of debt (21,379) (133)  
Foreign exchange and other 1,439 24,299  
Gain on investments, net 1,859 2,059  
Loss before recovery of income taxes (54,794) (13,181)  
Stock-based compensation expense 9,095 19,152  
Total assets 17,486,467   17,950,379
Identifiable intangible assets 9,227,321   9,308,669
Goodwill 5,165,247   5,141,366
Developed Markets
     
Segment reporting information      
Revenues 771,144 618,888  
Segment profit (loss) 185,253 155,719  
Total assets 12,521,653   12,859,099
Goodwill 4,004,793   3,988,795
Developed Markets | Eisai
     
Segment reporting information      
Identifiable intangible assets 112,000    
Developed Markets | Medicis, OraPharma, Eisai, J&J North America and University Medical
     
Segment reporting information      
Revenues 256,500    
Developed Markets | Medicis and legacy Valeant
     
Segment reporting information      
Segment profit (loss) 203,500    
Emerging Markets
     
Segment reporting information      
Revenues 297,211 237,215  
Segment profit (loss) 28,557 22,971  
Total assets 4,187,783   4,056,666
Goodwill 1,160,454   1,152,571
Emerging Markets | Natur Produkt
     
Segment reporting information      
Identifiable intangible assets 98,800    
Goodwill 34,700    
Emerging Markets | Natur Produkt, Gerot Lannach and Atlantis acquisitions
     
Segment reporting information      
Revenues 48,000    
Emerging Markets | Legacy Valeant
     
Segment reporting information      
Segment profit (loss) 56,500    
Total Segment
     
Segment reporting information      
Total assets 16,709,436   16,915,765
Corporate
     
Segment reporting information      
Segment profit (loss) (37,657) (34,358)  
Stock-based compensation expense 9,100 19,200  
Total assets $ 777,031   $ 1,034,614